Psychology
Microbiome-Gut-Brain Axis in Neuropsychiatric Disorders
Quick fact
The gut contains over 100 trillion bacteria, and their combined genetic material (the microbiome) can influence brain chemistry. Studies show that probiotic supplementation ('psychobiotics') can reduce symptoms of depression and anxiety in some patients, hinting at a new way to treat mental health.
Why this is interesting
You've probably felt 'butterflies' in your stomach when nervous. But what if the bacteria in your gut are not just responding to your emotions—but actually causing them?
Read the full explanation
Understanding Microbiome-Gut-Brain Axis in Neuropsychiatric Disorders
Imagine your gut as a bustling city of trillions of bacteria. These microbes are not just passive residents; they are active communicators. They send signals to your brain via the vagus nerve, which is like a superhighway connecting your gut to your brain. They also produce neurotransmitters—chemical messengers like serotonin and dopamine—that your brain uses. In fact, about 90% of your body's serotonin is made in your gut. When these microbes are unbalanced (a condition called dysbiosis), the signals they send can be distorted, potentially contributing to mood disorders like anxiety and depression. This communication is bidirectional: stress can alter the gut microbiome, and an unhealthy microbiome can send stress signals to the brain, creating a vicious cycle.
A deeper explanation
The microbiome-gut-brain axis operates through multiple interconnected pathways. First, the vagus nerve provides a direct neural connection: gut bacteria activate sensory nerve endings that relay information to the brainstem, influencing mood and behavior. Second, bacterial metabolites, such as short-chain fatty acids (SCFAs) produced from fiber fermentation, can cross the blood-brain barrier and modify brain function, including reducing inflammation. Third, gut microbes regulate the immune system by influencing the balance of pro- and anti-inflammatory cytokines. In dysbiosis, this balance shifts toward inflammation, which is increasingly recognized as a contributor to depressive and anxiety disorders. The HPA axis—the body's central stress response system—is also modulated by the microbiome, affecting cortisol release and the neuroendocrine response to stress. These mechanisms highlight how maintaining a healthy gut microbiome could be a novel therapeutic target for neuropsychiatric disorders, with probiotics, prebiotics, and dietary interventions being investigated as potential 'psychobiotics.'